Ericka Taylor-Daniel, APRN
Psychiatric/Mental Health · Dover, DENPI 1992186142
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $25,500 of the $39,481 with a category attached, or 64.6%. AbbVie accounts for 86.6% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2023 at $22,498 and has fallen 69.2% since, to $6,932 in 2025. Among psychiatric/mental health clinicians in DE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 327 payments — averaging $120.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$34K
- Johnson & Johnson$795
- Otsuka America Pharmaceutical, Inc.$759
- Neurocrine Biosciences, Inc.$700
- Teva Pharmaceuticals USA, Inc.$672
- Lundbeck LLC$463
- plus $2K from 22 others
What the payments were for
- Consulting fees$1,8805%
- Speaking & faculty fees$25,50065%
- Travel & lodging$4,84612%
- Food & beverage$7,09718%
- Education$1580%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 101 | $34,199 |
| Johnson & Johnson | 20 | $795 |
| Otsuka America Pharmaceutical, Inc. | 30 | $759 |
| Neurocrine Biosciences, Inc. | 35 | $700 |
| Teva Pharmaceuticals USA, Inc. | 29 | $672 |
| Lundbeck LLC | 23 | $463 |
| Alkermes, Inc. | 14 | $297 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $220 |
| Corium, LLC | 11 | $195 |
| Avanir Pharmaceuticals, Inc. | 8 | $140 |
| Vanda Pharmaceuticals Inc. | 4 | $115 |
| E.r. Squibb & Sons, L.L.C. | 5 | $113 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $108 |
| Gilead | 4 | $108 |
| Axsome Therapeutics, Inc. | 4 | $102 |
| Indivior Inc. | 5 | $85 |
| Supernus Pharmaceuticals, Inc. | 3 | $83 |
| Novo Nordisk | 3 | $58 |
| Smith+Nephew | 2 | $43 |
| Watermark Medical, Inc. | 2 | $40 |
| Braeburn Inc. | 2 | $35 |
| Sunovion Pharmaceuticals Inc. | 2 | $30 |
| Lilly USA, LLC | 1 | $25 |
| Shield Therapeutics Inc | 1 | $24 |
| Noven Therapeutics, LLC | 1 | $20 |
| AstraZeneca | 1 | $20 |
| Viiv Healthcare Company | 1 | $20 |
| Currax Pharmaceuticals LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Mavyret$20,330
- INGREZZA$361
- SPRAVATO$147
- ABILIFY MAINTENA$125
- ABILIFY ASIMTUFII$125
- REXULTI$125
- Austedo XR$120
How this compares
$39,481 in reported general payments places this provider in the 95th percentile of 177 psychiatric/mental health providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bydureon BciseExenatide Microspheres | 11 | $9,156 |
| Aripiprazole | 15 | $3,814 |
| Lurasidone Hcl | 13 | $1,651 |
| Fluoxetine Hcl | 78 | $1,472 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 15 | $1,020 |
| Trazodone Hcl | 19 | $385 |
| Risperidone | 21 | $378 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 15 | $363 |
| Bupropion XlBupropion Hcl | 19 | $331 |
| Ziprasidone Hcl | 11 | $237 |
| Bupropion Hcl SrBupropion Hcl | 14 | $221 |
| Hydroxyzine Pamoate | 15 | $85 |
| Propranolol Hcl | 11 | $61 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Dover
- Cindy CunninghamDover$14K
- Jeremy LegatesDover$3K
- Melchizedec BosireDover$3K
- Sherri ClarkDover$3K
- Maureen DarlingDover$3K
- Heather FryeDover$3K
- Morgan WebbDover$2K
- Ronald TyreeWilmington$59K
- Kameka HartNewark$10K
- Jenika MilesWilmington$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.